Drawing for TROVAX-VET

USPTO serial 78263331

TROVAX-VET

Reviewed by CopyMark Law Group

Reg. 3105831Status 710
Filing date
Status date
Registration date
Jun 20, 2006
Examiner
HOLTZ, ALLISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TROVAX-VET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kerry M. Regan

PHI LAN M TINSLEY KIRKPATRICK & LOCKHART NICHOLSON GRAHAM75 STATE STATTN TM ADMINISTRATORBOSTON, MA 02109-1808

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the treatment of cancer, auto-immune diseases, diseases of the nervous system, inflammatory diseases, vascular disorders and disorders arising from improper vascularisation; gene therapy and prophylaxis products for the veterinary treatment of cancer, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations; vaccines, gene therapy, prophylaxis vector and vector manufacturing preparations for the treatment of cancer in animals and humansSECTION 8 - CANCELLED—
010Instruments and apparatus for the administration of vaccines, namely, syringes and injectors; gene therapy and prophylaxis products, namely; syringes and injectors; surgical and medical apparatus and instruments for gene therapy and prophylaxis, pre-filled syringes, vials and injectors for medical purposes for animals and humansSECTION 8 - CANCELLED—
042Scientific and medical research and development for new products for animals and humans; genetic engineering services, namely, providing scientific researches for others in the fields of genetic engineering; biotechnology services, namely, providing research in the development of therapeutic and prophylactic products and vaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 25, 2013C8..CANCELLED SEC. 8 (6-YR)—
Jun 20, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 28, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 8, 2006NPUBNOTICE OF PUBLICATION—
Feb 10, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 9, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 20, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 17, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2005GNSIINQUIRY TO SUSPENSION E-MAILED—
May 18, 2005CNSISUSPENSION INQUIRY WRITTEN—
May 16, 2005RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 15, 2004GNSLLETTER OF SUSPENSION E-MAILED—
Nov 15, 2004CNSLSUSPENSION LETTER WRITTEN—
Oct 15, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 27, 2004ALIEASSIGNED TO LIE—
Sep 23, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 9, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 9, 2004MAILPAPER RECEIVED—
Jan 8, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance